• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受选择性经皮冠状动脉介入治疗且有或无前瞻性负荷试验的医疗保险患者的死亡率。

Mortality in Medicare patients undergoing elective percutaneous coronary intervention with or without antecedent stress testing.

作者信息

Lin Grace A, Lucas F Lee, Malenka David J, Skinner Jonathan, Redberg Rita F

机构信息

Division of General Internal Medicine, University ofCalifornia-San Francisco, 3333 California St, San Francisco, CA 94118, USA.

出版信息

Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):309-14. doi: 10.1161/CIRCOUTCOMES.113.000138. Epub 2013 May 14.

DOI:10.1161/CIRCOUTCOMES.113.000138
PMID:23674314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3808729/
Abstract

BACKGROUND

Guidelines advise testing for ischemia, such as with stress testing, before elective percutaneous coronary intervention (PCI). However, pre-PCI stress testing is not always done; the implications of this practice are not known. Our objective was to evaluate whether receipt of stress testing before elective PCI predicts mortality.

METHODS AND RESULTS

Using claims data from a 20% random sample of Medicare beneficiaries, we identified patients who had elective PCI in 2004 and followed them for a median of 3.4 years (n=23 887). Cox proportional hazards models were used to test the relationship of pre-PCI stress testing to survival. Population-based rates of elective PCI and stress testing were calculated for 306 hospital referral regions and categorized into 4 groups: high stress test/high PCI, low stress test/low PCI, low stress test/high PCI, and high stress/low PCI regions. Cox modeling was used to test whether category of hospital referral regions is related to survival. Patients who underwent pre-PCI stress testing had a 13% lower risk of mortality than those who did not (adjusted hazard ratio, 0.87; 95% confidence interval, 0.81-0.92) after median follow-up of 3.4 years. Patients in low stress test/high PCI regions had a 14% higher risk of mortality than those in high stress test/high PCI regions (adjusted hazard ratio, 1.14; 95% confidence interval, 1.03-1.26).

CONCLUSIONS

Pre-PCI stress testing is associated with lower mortality in patients undergoing elective PCI. Greater adherence to guidelines with respect to documenting ischemia before elective PCI may result in improved outcomes for patients.

摘要

背景

指南建议在择期经皮冠状动脉介入治疗(PCI)前进行缺血检测,如负荷试验。然而,PCI术前负荷试验并非总是进行;这种做法的影响尚不清楚。我们的目的是评估择期PCI前接受负荷试验是否可预测死亡率。

方法与结果

利用医疗保险受益人的20%随机样本的索赔数据,我们确定了2004年接受择期PCI的患者,并对他们进行了为期3.4年的中位数随访(n = 23887)。采用Cox比例风险模型来检验PCI术前负荷试验与生存之间的关系。计算了306个医院转诊区域的基于人群的择期PCI和负荷试验率,并将其分为4组:高负荷试验/高PCI、低负荷试验/低PCI、低负荷试验/高PCI和高负荷试验/低PCI区域。采用Cox模型来检验医院转诊区域类别是否与生存相关。在中位随访3.4年后,接受PCI术前负荷试验的患者的死亡风险比未接受者低13%(调整后的风险比,0.87;95%置信区间,0.81 - 0.92)。低负荷试验/高PCI区域的患者比高负荷试验/高PCI区域的患者死亡风险高14%(调整后的风险比,1.14;95%置信区间,1.03 - 1.26)。

结论

PCI术前负荷试验与接受择期PCI的患者较低的死亡率相关。在择期PCI前更严格地遵循关于记录缺血情况的指南可能会改善患者的预后。

相似文献

1
Mortality in Medicare patients undergoing elective percutaneous coronary intervention with or without antecedent stress testing.接受选择性经皮冠状动脉介入治疗且有或无前瞻性负荷试验的医疗保险患者的死亡率。
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):309-14. doi: 10.1161/CIRCOUTCOMES.113.000138. Epub 2013 May 14.
2
Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.在择期经皮冠状动脉介入治疗前,通过压力测试记录缺血情况的频率。
JAMA. 2008 Oct 15;300(15):1765-73. doi: 10.1001/jama.300.15.1765.
3
Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.欧洲心脏病学会和欧洲心胸外科学会指南对稳定型冠状动脉疾病血运重建策略的影响:经皮冠状动脉介入治疗和冠状动脉旁路移植术的活动变化。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):606-10. doi: 10.1016/j.jtcvs.2013.01.026. Epub 2013 Feb 10.
4
Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后心脏负荷试验模式的基于人群的研究。
Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). doi: 10.1161/CIRCOUTCOMES.117.003660.
5
Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®).经皮冠状动脉介入治疗后压力测试方式的模式和预测因素:来自 NCDR(®)的数据。
JACC Cardiovasc Imaging. 2012 Oct;5(10):969-80. doi: 10.1016/j.jcmg.2012.07.011.
6
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
7
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).接受经皮冠状动脉介入治疗的慢性肾脏病患者和非慢性肾脏病患者中断双联抗血小板治疗的发生率、模式和影响:PARIS 登记研究(支架置入患者抗血小板治疗方案不依从模式)的结果。
Circ Cardiovasc Interv. 2018 Mar;11(3):e006144. doi: 10.1161/CIRCINTERVENTIONS.117.006144.
8
Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.冠状动脉旁路移植术SYNTAX评分(紫杉醇药物洗脱支架与冠状动脉旁路移植术的协同作用)作为既往接受冠状动脉旁路移植术患者经皮冠状动脉介入治疗后预后标志物的验证
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003459.
9
Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.经皮冠状动脉血运重建术后的死亡率:既往心血管危险因素控制与糖尿病患者预后改善
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1195-1204. doi: 10.1002/ccd.26882. Epub 2016 Dec 28.
10
Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 Medicare beneficiaries.经皮冠状动脉介入治疗(PCI)术后行应激试验和诊断性心导管检查的应用:247052 名 Medicare 受益人群中,基于部位的应用模式与患者特征和结局的相关性。
J Am Coll Cardiol. 2013 Jul 30;62(5):439-46. doi: 10.1016/j.jacc.2013.02.093. Epub 2013 May 30.

引用本文的文献

1
Accurate diagnosis of severe coronary stenosis based on resting magnetocardiography: a prospective, single-center, cross-sectional analysis.基于静息磁心动图对重度冠状动脉狭窄的准确诊断:一项前瞻性、单中心横断面分析。
J Geriatr Cardiol. 2024 Apr 28;21(4):407-420. doi: 10.26599/1671-5411.2024.04.006.
2
Is more better? A multilevel analysis of percutaneous coronary intervention hospital openings and closures on patient volumes.更多更好吗?经皮冠状动脉介入治疗医院开放和关闭对患者量的多层次分析。
Acad Emerg Med. 2024 Oct;31(10):994-1005. doi: 10.1111/acem.14926. Epub 2024 May 16.
3
Magnetocardiography for the detection of myocardial ischemia.用于检测心肌缺血的磁心动图
Front Cardiovasc Med. 2023 Jul 7;10:1242215. doi: 10.3389/fcvm.2023.1242215. eCollection 2023.
4
Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test.经皮冠状动脉介入治疗患者行或不行术前运动压力测试的长期预后。
J Korean Med Sci. 2020 Jan 6;35(1):e3. doi: 10.3346/jkms.2020.35.e3.
5
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study.意大利缺血性心脏病患者经皮冠状动脉介入治疗的适宜性:APACHE 试点研究
BMJ Open. 2017 Sep 5;7(9):e016909. doi: 10.1136/bmjopen-2017-016909.

本文引用的文献

1
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告
Circulation. 2011 Dec 6;124(23):2574-609. doi: 10.1161/CIR.0b013e31823a5596. Epub 2011 Nov 7.
2
Appropriateness of percutaneous coronary intervention.经皮冠状动脉介入治疗的适宜性。
JAMA. 2011 Jul 6;306(1):53-61. doi: 10.1001/jama.2011.916.
3
Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.患者和心脏病专家对经皮冠状动脉介入治疗稳定型冠心病的获益的看法。
Ann Intern Med. 2010 Sep 7;153(5):307-13. doi: 10.7326/0003-4819-153-5-201009070-00005.
4
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.血流储备分数与血管造影术在指导经皮冠状动脉介入治疗中的比较
N Engl J Med. 2009 Jan 15;360(3):213-24. doi: 10.1056/NEJMoa0807611.
5
Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.在择期经皮冠状动脉介入治疗前,通过压力测试记录缺血情况的频率。
JAMA. 2008 Oct 15;300(15):1765-73. doi: 10.1001/jama.300.15.1765.
6
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.采用或不采用经皮冠状动脉介入治疗的优化药物治疗以减轻缺血负担:来自利用血运重建和强化药物评估的临床结果(COURAGE)试验核子亚研究的结果
Circulation. 2008 Mar 11;117(10):1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963. Epub 2008 Feb 11.
7
Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.功能性心脏检查在冠状动脉疾病诊断和管理中的成本效益:一项随机对照试验。CECaT试验。
Health Technol Assess. 2007 Dec;11(49):iii-iv, ix-115. doi: 10.3310/hta11490.
8
Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures.
Am Heart J. 2007 Oct;154(4):662-8. doi: 10.1016/j.ahj.2007.04.065.
9
Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease.心脏病专家对稳定型冠状动脉疾病采用经皮冠状动脉介入治疗的情况。
Arch Intern Med. 2007;167(15):1604-9. doi: 10.1001/archinte.167.15.1604.
10
Optimal medical therapy with or without PCI for stable coronary disease.稳定型冠心病接受或不接受经皮冠状动脉介入治疗的优化药物治疗
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.